FindTrial
Sign In

Predicting the Biological Behavior of Cerebral Arteriovenous Malformations Based on Vascular Architectural Feature Analysis

Predicting the Biological Behavior of Cerebral Arteriovenous Malformations Based on Vascular Architectural Feature Analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080829
Enrollment
Unknown
Registered
2024-02-08
Start date
2021-01-19
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Arteriovenous Malformation

Interventions

Patients with cerebral arteriovenous malformation:None
Healthy control individuals:None

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 80 Years

Inclusion criteria

Inclusion criteria: 1.Participants aged below 80 years, no gender restriction; 2.Diagnosed with cerebral arteriovenous malformations through MRA, CTA, or DSA; 3.Voluntary participation and signing of an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Previously treated cerebral arteriovenous malformations; 2.Concomitant cerebrovascular disorders such as dural arteriovenous fistulas, Moyamoya disease, or cerebral vasculature stenosis; 3.Presence of other malignant diseases with an expected lifespan of less than one year; 4.Other conditions deemed by the researcher as unsuitable for inclusion in the study.

Design outcomes

Primary

MeasureTime frame
Magnetic Resonance Imaging data;Epilepsy;Hemorrhagic Presentation of Cerebral Arteriovenous Malformations;—

Secondary

MeasureTime frame
Digital subtraction angiography data;—

Countries

China

Contacts

Public ContactChuhan Jiang

Beijing Tiantan Hospital, Capital Medical University

jiangchuhan126@126.com+86 139 1129 7825

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026